We were incorporated in Malaysia under the Companies Act 1965 on 27 July 2016 as a private limited company under the name of Nova Wellness Group Sdn Bhd. The Company is also deemed registered under the Act as at 31 January 2017. We subsequently converted to a public limited company on 31 October 2017 to facilitate our Listing.
Our principal activity is in investment holding while our subsidiary, Nova Laboratories is principally involved in the development, production and sales of nutraceutical and skincare products; and OEM development and production of nutraceutical products.
Nicholas Cheong Peck Hiang, aged 36, is our Group’s Chief Business Officer. He graduated from University of Northumbria, Newcastle, United Kingdom in 2004 with a Bachelor of Arts in Marketing.
He started his career as a sales representative with Hovid Pharmacy Sdn Bhd (a subsidiary of Hovid Berhad) in 2004 where he was involved in selling and promoting generic products. In 2005, he left Hovid Pharmacy Sdn Bhd to join Nova Laboratories as a sales representative and was promoted to sales manager in 2007.
As the sales manager of Nova Laboratories, he was responsible for managing overall sales, marketing and business development activities of Nova Laboratories. He also monitors the sales performance and marketing activities to private hospitals, clinics and retail pharmacies for Nova Laboratories.
He was promoted to our Group’s Chief Business Officer in 2015, a position he currently holds. As the Group’s Chief Business Officer, he assists Phang Yeen Nung and Phang Yeen Aun in business development and marketing, respectively.
Sangeetha A/P Thuraisingam, aged 33, is our Group’s Chief Quality Officer. She graduated from Tunku Abdul Rahman University, Malaysia with a Bachelor of Science in Biotechnology in 2006.
Upon graduation, she joined Nova Laboratories in 2006 as a regulatory executive where she was responsible for preparing registration dossiers for Nova Laboratories’ products and obtaining approval for the products from the NPRA and regulatory authorities. She was then promoted to Regulatory Manager in 2007 before being promoted to Regulatory & QA Manager in 2008. As Regulatory Manager, she was responsible for overseeing the development, implementation, maintenance and improvement of the GMP Quality System for our Group. She was also responsible to ensure that products meet safety, quality and efficacy requirements as well as product and manufacturing compliance with current GMP and relevant regulatory requirements.
In 2016, she was appointed to her current position of Chief Quality Officer where she is responsible for quality assurance of our Group’s operations through development, implementation and compliance with corporate policies, processes, procedures and guidelines relevant to regulatory activities. She is member of the Group’s internal Halal committee and in that capacity is responsible for the Halal compliance of the Group’s products and GMP plant. She is also the Vice Chairman of our internal health and safety committee and is responsible for inspections of the workplace for employees’ health and safety compliance and risk assessments for our Group’s manufacturing plant.
Tan Kiat Wei, aged 31, is our Group’s Chief Production Officer. He graduated from Cyberjaya University College of Medical Sciences, Malaysia with a Bachelor of Pharmacy in 2012.
He underwent training as a pharmacist trainee with Y.S.P. Industries (M) Sdn Bhd in 2012. After he completed his training in 2013, he became the production pharmacist to monitor the production process for the company’s cream manufacturing and packaging line and in that capacity was responsible to execute the production plans according to the schedule and to ensure the production runs smoothly. In 2014, he left Y.S.P. Industries (M) Sdn Bhd to join Nova Laboratories as a marketing manager. As the marketing manager, he was responsible for the planning of marketing programmes as well as conducting product training for the sales team.
In 2015, he was transferred to the production department as production manager where he was responsible for production planning and overseeing all production lines. Apart from overseeing the manufacturing process, he works closely with various departments to ensure our products meet the safety, quality and efficacy requirements and ensuring compliance with current GMP and relevant regulatory requirements. In 2016, he assumed his present position as our Group’s Chief Production Officer where he is responsible for overseeing the overall manufacturing process of our Group.